Over Cabrera
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 6
- Surgery top 1%
- Pancreatic function and diabetes 24
- Genetics top 2%
- Diabetes and associated disorders 10
- Pharmacology top 2%
- Cannabis and Cannabinoid Research 3
- Physiology top 5%
- Adenosine and Purinergic Signaling 3
-
- Metabolism, Diabetes, and Cancer 5
- Receptor Mechanisms and Signaling 3
- Co-authors
- Camillo RicordiPer‐Olof BerggrenAlejandro CaicedoNorma S. KenyonDora M. BermanAntonello PileggiR. Damaris MolanoKyle W. Sloop
- Journals
- Diabetes (5 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Over Cabrera
27 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Endocrinology, Diabetes and Metabolism 1.6k
- Surgery 2.1k
- Genetics 1.1k
- Pharmacology 421
- Physiology 94
Countries citing papers authored by Over Cabrera
This map shows the geographic impact of Over Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Over Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Over Cabrera more than expected).
Fields of papers citing papers by Over Cabrera
This network shows the impact of papers produced by Over Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Over Cabrera. The network helps show where Over Cabrera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Over Cabrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 23 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 12 | |
| 5 | LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptbreakdown → | 2018 | 603 |
| 6 | 2018 | 18 | |
| 7 | 2016 | 10 | |
| 8 | 2016 | 48 | |
| 9 | 2014 | 18 | |
| 10 | 2012 | 94 | |
| 11 | 2011 | 66 | |
| 12 | 2010 | 167 | |
| 13 | 2008 | 170 | |
| 14 | 2008 | 208 | |
| 15 | 2007 | 66 | |
| 16 | 2007 | 50 | |
| 17 | The unique cytoarchitecture of human pancreatic islets has implications for islet cell functionbreakdown → | 2006 | 938 |
| 18 | 2005 | 173 | |
| 19 | 2005 | 80 | |
| 20 | 2003 | 58 |
About Over Cabrera
Over Cabrera is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery, having authored 28 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (24 papers), Diabetes and associated disorders (10 papers), Diabetes Treatment and Management (9 papers), Diabetes Management and Research (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Adenosine and Purinergic Signaling (3 papers), Receptor Mechanisms and Signaling (3 papers) and Cannabis and Cannabinoid Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Surgery (2.1k citations) and Genetics (1.1k citations). Over Cabrera has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Camillo Ricordi, Per‐Olof Berggren, Alejandro Caicedo, Norma S. Kenyon, Dora M. Berman, Antonello Pileggi, R. Damaris Molano, Kyle W. Sloop, Jorge Alsina‐Fernandez and Corina Loghin. Their work appears in journals such as Diabetes, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Molecular Metabolism and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.